Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the ...

About 600 to 800 people develop acute promyelocytic leukemia (APL) in the United States each year. Leukemia is a group of cancers that develop in the cells that produce blood cells. It is ...

Historically, acute promyelocytic leukemia (APL) was considered to be one of the most fatal forms of acute leukemia with poor outcomes before the introduction of the vitamin A derivative all-trans ...

Acute promyelocytic leukemia (APL) is a type of acute myeloid leukemia (AML). With proper treatment, the survival rates are high. APL is a relatively rare cancer, accounting for about 7–8% of ...

Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia that is potentially curable with targeted therapies (such as all-trans retinoic acid and arsenic trioxide ...

Because this treatment uses very high doses of chemotherapy, it can cause serious complications like these: Acute promyelocytic leukemia (APL) is a subtype of AML that doctors treat a little ...

B-cell ALL has several subtypes, including mature B-cell ALL or Burkitt’s leukemia. AML has various subtypes, including acute promyelocytic leukemia. Doctors classify these leukemias depending ...

For example, uncontrolled bleeding is seen in the M3 subtype of AML, also known as acute promyelocytic leukemia (APL). The subtypes also predict prognosis and identify the best suitable treatment.

For Shenderov, the disease in the spotlight is acute promyelocytic leukemia (APL), a rare subform of leukemia that affects the white blood cells. Only 800 Americans are diagnosed with it each year.

For instance, one type is called acute promyelocytic leukemia (APL), which occurs when genes from chromosomes 15 and 17 switch places, creating an abnormal gene. This gene prevents a type of white ...

Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) and is characterized by a unique molecular abnormality. This type of leukemia has a high mortality rate and is ...

The introduction of all-trans retinoic acid in 1985 combined with anthracycline-based chemotherapy has revolutionized the prognosis of acute promyelocytic leukemia (APL) with current complete ...